M. Winkelmann

562 total citations
23 papers, 403 citations indexed

About

M. Winkelmann is a scholar working on Hematology, Genetics and Nephrology. According to data from OpenAlex, M. Winkelmann has authored 23 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Genetics and 4 papers in Nephrology. Recurrent topics in M. Winkelmann's work include Platelet Disorders and Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). M. Winkelmann is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). M. Winkelmann collaborates with scholars based in Germany, Netherlands and France. M. Winkelmann's co-authors include P Pfitzer, Friedrich Kapp, Volker Auwärter, Maren Hermanns‐Clausen, Hans H. Maurer, Wolfgang Schneider, B. Grabensee, W Stangel, I. Schedel and Wolfgang Klosterhalfen and has published in prestigious journals such as Cancer, International Journal of Molecular Sciences and Journal of Molecular Medicine.

In The Last Decade

M. Winkelmann

19 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Winkelmann Germany 10 124 88 85 81 68 23 403
Gundula Grimberg Germany 9 63 0.5× 117 1.3× 33 0.4× 142 1.8× 13 0.2× 9 630
Shaojian An United States 7 21 0.2× 62 0.7× 54 0.6× 225 2.8× 33 0.5× 10 454
Ebru Şener Türkiye 13 56 0.5× 32 0.4× 27 0.3× 69 0.9× 31 0.5× 31 392
Yasushi Mizumoto Japan 11 38 0.3× 66 0.8× 69 0.8× 267 3.3× 22 0.3× 14 566
Tor‐Erik Sand Norway 15 59 0.5× 105 1.2× 26 0.3× 296 3.7× 23 0.3× 19 614
Manabu Matsunawa Japan 9 27 0.2× 67 0.8× 12 0.1× 135 1.7× 17 0.3× 22 401
J Simon United States 2 17 0.1× 18 0.2× 92 1.1× 72 0.9× 19 0.3× 2 379
Nico J. Ponne Netherlands 10 49 0.4× 453 5.1× 31 0.4× 308 3.8× 17 0.3× 11 782
Shigeyoshi Honma Japan 10 29 0.2× 23 0.3× 29 0.3× 134 1.7× 18 0.3× 19 343
Vishal S. Narang United States 8 47 0.4× 182 2.1× 42 0.5× 104 1.3× 25 0.4× 10 345

Countries citing papers authored by M. Winkelmann

Since Specialization
Citations

This map shows the geographic impact of M. Winkelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Winkelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Winkelmann more than expected).

Fields of papers citing papers by M. Winkelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Winkelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Winkelmann. The network helps show where M. Winkelmann may publish in the future.

Co-authorship network of co-authors of M. Winkelmann

This figure shows the co-authorship network connecting the top 25 collaborators of M. Winkelmann. A scholar is included among the top collaborators of M. Winkelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Winkelmann. M. Winkelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruhnau, Johanna, et al.. (2025). Lack of Negative Feedback Loops of CTLA-4 and PD-L1 as Key Mechanisms for Post-Acute T Cell Activation Until 3 Months After Ischemic Stroke. International Journal of Molecular Sciences. 26(23). 11489–11489.
2.
Kapp, Friedrich, Hans H. Maurer, Volker Auwärter, M. Winkelmann, & Maren Hermanns‐Clausen. (2011). Intrahepatic Cholestasis Following Abuse of Powdered Kratom (Mitragyna speciosa). Journal of Medical Toxicology. 7(3). 227–231. 116 indexed citations
3.
Winkelmann, M., et al.. (2008). Therapie der chronischen idiopathischen thrombozytopenischen Purpura. DMW - Deutsche Medizinische Wochenschrift. 112(6). 221–224.
4.
Schmitt‐Graeff, Annette, et al.. (2008). Pfortaderaneurysma und Leberfibrose bei Myelofibrose. DMW - Deutsche Medizinische Wochenschrift. 107(51/52). 1969–1972.
5.
Winkelmann, M., et al.. (2008). Tödlich verlaufene immnunhämolytische Anämie nach Genuß des Kahlen Kremplings (Paxillus involutus). DMW - Deutsche Medizinische Wochenschrift. 107(31/32). 1190–1194. 5 indexed citations
6.
Gerharz, Claus‐Dieter, et al.. (1996). Association of primary renal non-Hodgkin's lymphoma with mesangioproliferative glomerulonephritis. American Journal of Hematology. 53(2). 126–132. 9 indexed citations
7.
Heyll, A., Carlo Aul, Volker Runde, et al.. (1994). Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia. Annals of Hematology. 68(6). 279–283. 14 indexed citations
8.
Aul, Carlo, Norbert Gattermann, Ulrich Germing, et al.. (1994). Serum deoxythymidine kinase in myelodysplastic syndromes. Cancer. 73(2). 322–327. 7 indexed citations
9.
Stockhorst, Ursula, et al.. (1993). Anticipatory nausea in cancer patients receiving chemotherapy: Classical conditioning etiology and therapeutical implications. Integrative Psychological and Behavioral Science. 28(2). 177–181. 31 indexed citations
10.
Winkelmann, M., K Ebeling, G Strohmeyer, et al.. (1992). Treatment results of the thioether lipid ilmofosine in patients with malignant tumours. Journal of Cancer Research and Clinical Oncology. 118(6). 405–407. 13 indexed citations
11.
Büchler, Markus W., Helmut Frieß, C Gebhardt, et al.. (1991). A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer. 68(7). 1507–1512. 69 indexed citations
12.
Winkelmann, M., et al.. (1989). Lavage fluid from continuous ambulatory peritoneal dialysis. A model for mesothelial cell changes.. PubMed. 33(5). 591–4. 4 indexed citations
13.
Winkelmann, M., Carlo Aul, Rüdiger E. Scharf, et al.. (1987). Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14. Journal of Molecular Medicine. 65(21). 1034–1041. 9 indexed citations
14.
Winkelmann, M., et al.. (1987). Correlation of abdominal CT imaging with autopsy findings in patients with malignant tumors. Journal of Cancer Research and Clinical Oncology. 113(3). 279–284. 8 indexed citations
15.
Winkelmann, M., P Pfitzer, & Wolfgang Schneider. (1987). Significance of polyploidy in megakaryocytes and other cells in health and tumor disease. Journal of Molecular Medicine. 65(23). 1115–1131. 40 indexed citations
16.
Winkelmann, M., W Stangel, I. Schedel, & B. Grabensee. (1986). Severe hemolysis caused by antibodies against the mushroomPaxillus involutus and its therapy by plasma exchange. Journal of Molecular Medicine. 64(19). 935–938. 28 indexed citations
17.
Winkelmann, M., U. Dörr, P Pfitzer, & Wolfgang Schneider. (1986). Is lower ploidy of megakaryocytes another reason for uremic thrombocytopathy?. Journal of Molecular Medicine. 64(12). 540–544. 9 indexed citations
18.
Winkelmann, M., B. Grabensee, & P Pfitzer. (1985). Differential Diagnosis of Acute Allograft Rejection and CMV-Infection in Renal Transplantation by Urinary Cytology. Pathology - Research and Practice. 180(2). 161–168. 3 indexed citations
19.
Pfitzer, P, M. Winkelmann, & W Schneider. (1983). [Polyploidy patterns of megakaryocytes in patients with thrombotic paraneoplasia and in controls].. PubMed. 67. 478–82. 1 indexed citations
20.
Winkelmann, M. & P Pfitzer. (1981). Blind pleural biopsy in combination with cytology of pleural effusions.. PubMed. 25(4). 373–6. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gundula Grimberg Breakdown of academic impact, for papers by Shaojian An Breakdown of academic impact, for papers by Ebru Şener Breakdown of academic impact, for papers by Yasushi Mizumoto Breakdown of academic impact, for papers by Tor‐Erik Sand Breakdown of academic impact, for papers by Manabu Matsunawa Breakdown of academic impact, for papers by J Simon Breakdown of academic impact, for papers by Nico J. Ponne Breakdown of academic impact, for papers by Shigeyoshi Honma Breakdown of academic impact, for papers by Vishal S. Narang
Rankless by CCL
2026